{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:23:06Z","timestamp":1777630986881,"version":"3.51.4"},"reference-count":18,"publisher":"British Editorial Society of Bone & Joint Surgery","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/online.boneandjoint.org.uk\/TDM"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Bone and Joint Surgery. British volume"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:p> Total hip replacement in patients with Gaucher\u2019s disease with symptomatic osteonecrosis of the femoral head is controversial because of the high early failure rates. We describe four patients who had an uncemented total hip replacement following enzyme replacement therapy for a median of two years and one month (1 to 9.8 years) prior to surgery, and who remained on treatment. At operation, the bone had a normal appearance and consistency. Histopathological examination showed that, compared with previous biopsies of untreated Gaucher\u2019s disease, the Gaucher cell infiltrate had decreased progressively with therapy, being replaced by normal adipose tissue. The surfaces of viable bone beyond the osteonecrotic areas showed osteoblasts, indicating remodelling. In one case acetabular revision was carried out after 11 years and eight months. The three remaining patients had a mean follow-up of six years and four months (3.3 to 12 years). We recommend initiating enzyme replacement therapy at least one to two years prior to total hip replacement to facilitate bone remodelling and to allow implantation of uncemented components in these young patients. <\/jats:p>","DOI":"10.1302\/0301-620x.91b12.22515","type":"journal-article","created":{"date-parts":[[2009,11,30]],"date-time":"2009-11-30T22:40:02Z","timestamp":1259620802000},"page":"1623-1627","source":"Crossref","is-referenced-by-count":12,"title":["Total hip replacement in Gaucher\u2019s disease"],"prefix":"10.1302","volume":"91-B","author":[{"given":"V.","family":"Bubbar","sequence":"first","affiliation":[{"name":"Division of Orthopaedic Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Las","family":"Heras","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Amato","sequence":"additional","affiliation":[{"name":"Department of Medicine Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada M5G 1X."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. P. H.","family":"Pritzker","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. E.","family":"Gross","sequence":"additional","affiliation":[{"name":"Division of Orthopaedic Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"42","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2003.10.067"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Itzchaki M, Lebel E, Dweck A, et al. Orthopedic considerations in Gaucher disease since the advent of enzyme replacement therapy. Acta Orthop Scand 2004;75:641\u201353.","DOI":"10.1080\/00016470410004003"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Mankin HJ, Rosenthal DI, Xavier R. Gaucher disease: new approaches to an ancient disease. J Bone Joint Surg [Am] 2001;83-A:748\u201362.","DOI":"10.2106\/00004623-200105000-00016"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Lachiewicz P. Gaucher\u2019s disease. Orthop Clin North Am 1984;15:765\u201374.","DOI":"10.1016\/S0030-5898(20)31268-2"},{"key":"R5","unstructured":"Lebel E, Itzchaki M, Elstein D, et al. Skeletal manifestations in Gaucher\u2019s disease: presentation and treatment. Isr Med Assoc J 1999;1:267\u201371."},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1054\/arth.2002.33272"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1054\/arth.2001.19162"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Lau MM, Lichtman DM, Hamati YI, Bierbaum BE. Hip arthroplasties in Gaucher\u2019s disease. J Bone Joint Surg [Am] 1981;63-A:591\u2013601.","DOI":"10.2106\/00004623-198163040-00009"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Lachiewicz PF, Lane JM, Wilson PD Jr. Total hip replacement in Gaucher\u2019s disease. J Bone Joint Surg [Am] 1981;63-A:602\u20138.","DOI":"10.2106\/00004623-198163040-00010"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Goldblatt J, Sacks S, Dall D, Beighton P. Total hip arthroplasty in Gaucher\u2019s disease: long-term prognosis. Clin Orthop 1988;228:94\u20138.","DOI":"10.1097\/00003086-198803000-00014"},{"key":"R11","unstructured":"Van Wellen PAJ, Haentjens P, Frecoult N, Opdecam P. Loosening of a nonce-mented porous-coated anatomic femoral component in Gaucher\u2019s disease: a case report and review of the literature. Acta Orthop Belg 1994;60:119\u201323."},{"key":"R12","unstructured":"Sellman DC, Froimson AI. Long-term follow-up of a total articular resurfacing arthroplasty and a cup arthroplasty in Gaucher\u2019s disease. Orthopaedic Review 1992;21:1099\u2013101, 1104, 1107."},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Laporte D, Mont M, Hungerford DS. Proximally porous-coated ingrowth prostheses: limits of use. Orthop 1999;22:1154\u201360.","DOI":"10.3928\/0147-7447-19991201-09"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1177\/112070000701700308"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Poll LW, Maas M, Terk MR, et al. Response of Gaucher bone disease to enzyme replacement therapy. Br J Radiol 2002;74 (Suppl 1):25\u201336.","DOI":"10.1259\/bjr.75.suppl_1.750025"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2003.00047.x"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Wenstrup RJ, Kacena KA, Kaplan P, et al. Effect of enzyme replacement therapy with imiglucerase on BMD in type I Gaucher disease. J Bone Miner Res 2007;22:119\u201326.","DOI":"10.1359\/jbmr.061004"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Andersson H, Kaplan P, Kacena K, Yee J. Eight-year clinical outcomes of long-term enzyme replacement therapy for 884 children with Gaucher disease type I. Pediactrics 2008;122:1182\u201390.","DOI":"10.1542\/peds.2007-2144"}],"container-title":["The Journal of Bone and Joint Surgery. British volume"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/online.boneandjoint.org.uk\/doi\/pdf\/10.1302\/0301-620X.91B12.22515","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/online.boneandjoint.org.uk\/doi\/full-xml\/10.1302\/0301-620X.91B12.22515","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/online.boneandjoint.org.uk\/doi\/pdf\/10.1302\/0301-620X.91B12.22515","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T18:23:19Z","timestamp":1629138199000},"score":1,"resource":{"primary":{"URL":"https:\/\/online.boneandjoint.org.uk\/doi\/10.1302\/0301-620X.91B12.22515"}},"subtitle":["EFFECTS OF ENZYME REPLACEMENT THERAPY"],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["10.1302\/0301-620X.91B12.22515"],"URL":"https:\/\/doi.org\/10.1302\/0301-620x.91b12.22515","relation":{},"ISSN":["0301-620X","2044-5377"],"issn-type":[{"value":"0301-620X","type":"print"},{"value":"2044-5377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}